Specifically, the identification of miRNAs such as miR-129, miR-19a-3p, and miR-30d-5p, as well as proteins like COL4A1, MAPK3, PIK3CG, and mTOR, provides valuable insights into the molecular mechanisms underpinning aggressive breast cancer subtypes, such as TNBC. Here, MTOR is linked to breast carcinoma.